XML 76 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Shareholders' Equity and Redeemable Noncontrolling Interest - USD ($)
$ in Thousands
Total
Redeemable Noncontrolling Interest [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Subscriptions Receivables [Member]
AOCI Attributable to Parent [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Balance, temporary equity at Mar. 31, 2019   $ 50,130            
Balance at Mar. 31, 2019 $ 887,169   $ 0 $ 3,024,172 $ 0 $ 2,518 $ (2,309,737) $ 170,216
Balance, shares at Mar. 31, 2019     213,555,119          
Issuance of subsidiary convertible and redeemable preferred stock, net   27,491            
Purchase of subsidiary convertible and redeemable preferred stock (77,777) (55,130)   (77,777)        
Issuance of subsidiary common shares, net of issuance costs paid 117,658     59,052       58,606
Issuance of subsidiary common shares to the Company       (9,962)       9,962
Purchase of subsidiary common shares (65,544)     (62,913)       (2,631)
Issuance of subsidiary warrants 907             907
Exercise of subsidiary stock options 1,407     875       532
Issuance of the Company's common shares 999,193     999,193        
Issuance of the Company's common shares, net, shares     26,952,143          
Repurchase of common shares and other equity instruments (990,014)     (990,014)        
Repurchase of common shares and other equity instruments, shares     (25,625,933)          
Sale of interests in subsidiaries (43,398)             (43,398)
Issuance of equity by subsidiary upon Business Combination and recapitalization 104,686     69,379       35,307
Issuance of equity by subsidiary to the Company upon Business Combination and recapitalization       (2,559)       2,559
Conversion of subsidiary convertible promissory notes 33,087     21,928       11,159
Issuance of equity instruments 24,842     24,842        
Settlement in equity of liability-classified instruments 13,119     13,119        
Deconsolidation of subsidiary (46,483)             (46,483)
Cash contributions to majority-owned subsidiaries       (4,699)       4,699
Share-based compensation 122,572     79,103       43,469
Share-based compensation, shares     (2,271)          
Foreign currency translation adjustment (5,536)         (4,867)   (669)
Net loss 1,010,316           1,200,509 (190,193)
Balance, temporary equity at Mar. 31, 2020   22,491            
Balance at Mar. 31, 2020 2,086,204 22,491 $ 0 3,143,739 0 (2,349) (1,109,228) 54,042
Balance, shares at Mar. 31, 2020     214,879,058          
Issuance of subsidiary common shares, net of issuance costs paid 181,180     104,581       76,599
Issuance of subsidiary common shares to the Company 0     (6,342)       6,342
Exercise of subsidiary stock options 63     36       27
Deconsolidation of subsidiary (3,054)             (3,054)
Repurchase of equity awards (113)     (113)        
Cash contributions to majority-owned subsidiaries 0     (149)       149
Share-based compensation 14,278     9,285       4,993
Foreign currency translation adjustment (820)         (854)   34
Net loss (7,977)           (3,243) (4,734)
Balance at Jun. 30, 2020 2,269,761 22,491 $ 0 3,251,037 0 (3,203) (1,112,471) 134,398
Balance, shares at Jun. 30, 2020     214,879,058          
Balance, temporary equity at Mar. 31, 2020   22,491            
Balance at Mar. 31, 2020 2,086,204 22,491 $ 0 3,143,739 0 (2,349) (1,109,228) 54,042
Balance, shares at Mar. 31, 2020     214,879,058          
Issuance of subsidiary common shares, net of issuance costs paid 456,097     324,995 (100,000)     231,102
Issuance of subsidiary common shares to the Company       (11,692)       11,692
Issuance of the Company's common shares 301,744 0 $ 0 301,744 0 0 0 0
Issuance of the Company's common shares, net, shares     7,202,917          
Exercise of subsidiary stock options and vesting of subsidiary restricted stock units 907     522       385
Deconsolidation of subsidiary (3,054)             (3,054)
Consolidation of unconsolidated entity 9,178             9,178
Repurchase of equity awards (113)     (113)        
Cash contributions to majority-owned subsidiaries       (1,642)       1,642
Share-based compensation 84,958     57,252       27,706
Share-based compensation, shares     587,824          
Foreign currency translation adjustment 3,826         3,794   32
Net loss (900,233)           (809,234) (90,999)
Balance, temporary equity at Mar. 31, 2021   22,491            
Balance at Mar. 31, 2021 2,039,514 22,491 $ 0 3,814,805 (100,000) 1,445 (1,918,462) 241,726
Balance, shares at Mar. 31, 2021     222,669,799          
Issuance of subsidiary warrants 2,075     2,051       24
Cash contributions to majority-owned subsidiaries 0     (2,973)       2,973
Share-based compensation 19,269     11,091       8,178
Foreign currency translation adjustment (2,439)         (2,652)   213
Net loss (101,078)           (82,183) (18,895)
Balance at Jun. 30, 2021 $ 1,957,341 $ 22,491 $ 0 $ 3,824,974 $ (100,000) $ (1,207) $ (2,000,645) $ 234,219
Balance, shares at Jun. 30, 2021     222,669,799